Literature DB >> 10790110

Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir-resistant viral infection.

T Suzutani1, M Saijo, M Nagamine, M Ogasawara, M Azuma.   

Abstract

A rapid phenotypic screening method for herpes simplex virus (HSV) and varicella-zoster virus (VZV) thymidine kinase (TK) genes was developed for monitoring acyclovir-resistant viruses. This method determines the biochemical phenotype of the TK polypeptide, which is synthesized in vitro from viral DNA using a procedure as follows. The TK gene of each sample virus strain is amplified and isolated under the control of a T7 promoter by PCR. The PCR products are transcribed with T7 RNA polymerase and translated in a rabbit reticulocyte lysate. Using this method, enzymatic characteristics and the size of the TK polypeptides encoding HSV and VZV DNA were defined in less than 2 days without virus isolation. The assay should be a powerful tool in monitoring drug-resistant viruses, especially in cases in which virus isolation is difficult.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10790110      PMCID: PMC86603     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  42 in total

1.  Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus.

Authors:  S M Swetter; E L Hill; E R Kern; D M Koelle; C M Posavad; W Lawrence; S Safrin
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

2.  A rapid assay to screen for drug-resistant herpes simplex virus.

Authors:  P Tebas; D Scholl; J Jollick; K McHarg; M Arens; P D Olivo
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

Review 3.  Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations.

Authors:  R J Whitley; F Lakeman
Journal:  Clin Infect Dis       Date:  1995-02       Impact factor: 9.079

4.  Recurrent acyclovir-resistant herpes simplex in an immunocompromised patient: can strain differences compensate for loss of thymidine kinase in pathogenesis?

Authors:  B C Horsburgh; S H Chen; A Hu; G B Mulamba; W H Burns; D M Coen
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

5.  Acyclovir-resistant neonatal herpes simplex virus infection of the larynx.

Authors:  A C Nyquist; H A Rotbart; M Cotton; C Robinson; A Weinberg; A R Hayward; R L Berens; M J Levin
Journal:  J Pediatr       Date:  1994-06       Impact factor: 4.406

6.  Molecular analysis of a neurovirulent herpes simplex virus type 2 strain with reduced thymidine kinase activity.

Authors:  S Tanaka; Y Toh; R Mori
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 7.  Herpes simplex virus resistance to acyclovir: clinical relevance.

Authors:  J C Pottage; H A Kessler
Journal:  Infect Agents Dis       Date:  1995-09

8.  Analysis of the relationship between cellular thymidine kinase activity and virulence of thymidine kinase-negative herpes simplex virus types 1 and 2.

Authors:  T Suzutani; S Koyano; M Takada; I Yoshida; M Azuma
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

9.  Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey.

Authors:  F Nugier; J N Colin; M Aymard; M Langlois
Journal:  J Med Virol       Date:  1992-01       Impact factor: 2.327

10.  Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir.

Authors:  P Collins; M N Ellis
Journal:  J Med Virol       Date:  1993       Impact factor: 2.327

View more
  6 in total

1.  Generation of a reporter cell line for detection of infectious varicella-zoster virus and its application to antiviral studies.

Authors:  Guan-Qing Wang; Tatsuo Suzutani; Yumiko Yamamoto; Yoshiko Fukui; Naoki Nozawa; D Scott Schmid; Ichiro Kurane; Naoki Inoue
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Herpes simplex virus thymidine kinase mutations associated with resistance to acyclovir: a site-directed mutagenesis study.

Authors:  E Frobert; T Ooka; J C Cortay; B Lina; D Thouvenot; F Morfin
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Identification of a varicella-zoster virus replication inhibitor that blocks capsid assembly by interacting with the floor domain of the major capsid protein.

Authors:  Naoki Inoue; Misato Matsushita; Yoshiko Fukui; Souichi Yamada; Mihoko Tsuda; Chizuka Higashi; Keiko Kaneko; Hideki Hasegawa; Toyofumi Yamaguchi
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

Review 4.  Antiviral drug resistance: mechanisms and clinical implications.

Authors:  Lynne Strasfeld; Sunwen Chou
Journal:  Infect Dis Clin North Am       Date:  2010-06       Impact factor: 5.982

5.  [Liver cirrhosis patogenetics: polymorphism of glutation S-transferase genes].

Authors:  I A Goncharova; M I Rachkovskiĭ; E V Beloborodova; Kh Gamal' Abd El'-Aziz Nasar; V P Puzyrev
Journal:  Mol Biol (Mosk)       Date:  2010 May-Jun

6.  Recombinant herpes simplex virus type 1 strains with targeted mutations relevant for aciclovir susceptibility.

Authors:  Anne-Kathrin Brunnemann; Kristin Liermann; Stefanie Deinhardt-Emmer; Gregor Maschkowitz; Anja Pohlmann; Beate Sodeik; Helmut Fickenscher; Andreas Sauerbrei; Andi Krumbholz
Journal:  Sci Rep       Date:  2016-07-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.